Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain.
about
Efficacy and Safety of Tanezumab on Osteoarthritis Knee and Hip Pains: A Meta-Analysis of Randomized Controlled Trials.Evaluation of the Effects of Tanezumab, a Monoclonal Antibody Against Nerve Growth Factor, on the Sympathetic Nervous System in Adult Cynomolgus Monkeys (Macaca fascicularis): A Stereologic, Histomorphologic, and Cardiofunctional Assessment.Tanezumab in the treatment of chronic musculoskeletal conditions.Tanezumab: a selective humanized mAb for chronic lower back pain.First-in-human randomized clinical trials of the safety and efficacy of tanezumab for treatment of chronic knee osteoarthritis pain or acute bunionectomy pain.Pharmacokinetics and C-reactive protein modelling of anti-interleukin-6 antibody (PF-04236921) in healthy volunteers and patients with autoimmune disease
P2860
Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Population pharmacokinetics of ...... rials for osteoarthritis pain.
@ast
Population pharmacokinetics of ...... rials for osteoarthritis pain.
@en
type
label
Population pharmacokinetics of ...... rials for osteoarthritis pain.
@ast
Population pharmacokinetics of ...... rials for osteoarthritis pain.
@en
prefLabel
Population pharmacokinetics of ...... rials for osteoarthritis pain.
@ast
Population pharmacokinetics of ...... rials for osteoarthritis pain.
@en
P2093
P2860
P356
P1476
Population pharmacokinetics of ...... rials for osteoarthritis pain.
@en
P2093
E Niclas Jonsson
Rosalin H Arends
Scott F Marshall
P2860
P304
P356
10.1111/BCP.12850
P407
P577
2015-11-27T00:00:00Z